JP2023500060A5 - - Google Patents
Info
- Publication number
- JP2023500060A5 JP2023500060A5 JP2022523485A JP2022523485A JP2023500060A5 JP 2023500060 A5 JP2023500060 A5 JP 2023500060A5 JP 2022523485 A JP2022523485 A JP 2022523485A JP 2022523485 A JP2022523485 A JP 2022523485A JP 2023500060 A5 JP2023500060 A5 JP 2023500060A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- treatment
- compound
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924556P | 2019-10-22 | 2019-10-22 | |
| EP19000483 | 2019-10-22 | ||
| EP19000483.8 | 2019-10-22 | ||
| US62/924,556 | 2019-10-22 | ||
| EP20163777 | 2020-03-17 | ||
| EP20163777.4 | 2020-03-17 | ||
| EP20176336 | 2020-05-25 | ||
| EP20176336.4 | 2020-05-25 | ||
| PCT/EP2020/079802 WO2021078889A1 (en) | 2019-10-22 | 2020-10-22 | Methods and compositions for treating sickle cell disease with a ferroportin inhibitor (vit-2763) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500060A JP2023500060A (ja) | 2023-01-04 |
| JP2023500060A5 true JP2023500060A5 (https=) | 2023-06-06 |
| JP7594004B2 JP7594004B2 (ja) | 2024-12-03 |
Family
ID=73005635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523485A Active JP7594004B2 (ja) | 2019-10-22 | 2020-10-22 | フェロポーチン阻害剤（ｖｉｔ－２７６３）を用いる鎌状赤血球症を治療するための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220274973A1 (https=) |
| EP (1) | EP4048262A1 (https=) |
| JP (1) | JP7594004B2 (https=) |
| KR (1) | KR20220086563A (https=) |
| CN (1) | CN114765955B (https=) |
| AU (1) | AU2020369137A1 (https=) |
| BR (1) | BR112022007616A2 (https=) |
| CA (1) | CA3154524A1 (https=) |
| IL (1) | IL291137A (https=) |
| MX (1) | MX2022004806A (https=) |
| WO (1) | WO2021078889A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025519535A (ja) * | 2022-06-07 | 2025-06-26 | プロタゴニスト セラピューティクス， インコーポレイテッド | 鎌状赤血球病の治療のためのヘプシジン模倣体 |
| AU2023362497A1 (en) | 2022-10-21 | 2025-04-24 | Vifor (International) Ag | Bicyclic ferroportin inhibitors |
| KR20260028017A (ko) | 2023-06-26 | 2026-03-03 | 비포르 (인터내셔날) 아게 | 유전성 혈색소침착증(hh)의 치료에 사용하기 위한 페로포틴-저해제 |
| WO2026041650A1 (en) | 2024-08-20 | 2026-02-26 | Vifor (International) Ag | Ferroportin-inhibitors for the use in the treatment of lupus nephritis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA123219C2 (uk) | 2015-10-23 | 2021-03-03 | Віфор (Інтернаціональ) Аґ | Інгібітори феропортину |
| IL264372B2 (en) * | 2016-08-04 | 2024-05-01 | Baxalta Inc | Adamts13 for use in treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease |
| JOP20180036A1 (ar) | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
| US11286243B2 (en) | 2018-12-13 | 2022-03-29 | Global Blood Therapeutics, Inc. | Ferroportin inhibitors and methods of use |
-
2020
- 2020-10-22 KR KR1020227012237A patent/KR20220086563A/ko active Pending
- 2020-10-22 BR BR112022007616A patent/BR112022007616A2/pt unknown
- 2020-10-22 AU AU2020369137A patent/AU2020369137A1/en active Pending
- 2020-10-22 MX MX2022004806A patent/MX2022004806A/es unknown
- 2020-10-22 JP JP2022523485A patent/JP7594004B2/ja active Active
- 2020-10-22 CA CA3154524A patent/CA3154524A1/en active Pending
- 2020-10-22 EP EP20796575.7A patent/EP4048262A1/en active Pending
- 2020-10-22 US US17/636,575 patent/US20220274973A1/en not_active Abandoned
- 2020-10-22 CN CN202080074094.0A patent/CN114765955B/zh active Active
- 2020-10-22 WO PCT/EP2020/079802 patent/WO2021078889A1/en not_active Ceased
-
2022
- 2022-03-06 IL IL291137A patent/IL291137A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023500060A5 (https=) | ||
| JP7660600B2 (ja) | 慢性炎症性疾患および／または自己免疫疾患の予防または治療における使用のためのビドフルジムス（Ｖｉｄｏｆｌｕｄｉｍｕｓ）の投与レジメン | |
| EP2222314B1 (en) | Uses and means for otaining bronchorelaxation | |
| JP6353577B2 (ja) | 組み合わせ組成物 | |
| TW200520762A (en) | Compositions and methods for topical treatment of skin infection | |
| EP4574136A2 (en) | Compositions for the treatment of hypertension | |
| WO2007001961A2 (en) | Method for the treatment of acne | |
| FI4426298T3 (fi) | Uusia terapeuttisia yhdistelmiä, jotka käsittävät pirfenidonia ja pde4-estäjää, etenevien fibrosoivien interstitiaalisten keuhkosairauksien hoitamiseksi | |
| US20170319519A1 (en) | Combination for the treatment of conditions involving muscular pain | |
| CA2206995C (en) | Use of alkanoyl l-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases | |
| WO2020055226A1 (es) | Combinación farmacéutica sinérgica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona | |
| HRP20241621T1 (hr) | (1r,3s)-3-((5-cijano-4-feniltiazol-2-il)karbamoil)ciklopentan-1-karboksilna kiselina, namijenjena upotrebi u liječenju bolesti dišnih puteva | |
| JP2023538419A5 (https=) | ||
| AU2024203992B2 (en) | Prophylactic or therapeutic agent for porphyria | |
| JP2022518288A5 (https=) | ||
| US4175128A (en) | Method for treating congestive heart failure | |
| WO2004017973A1 (ja) | 統合失調症治療剤 | |
| JP6188784B2 (ja) | 炎症性および免疫性疾患の治療のための組成物 | |
| Poole-Wilson | Timolol maleate (MK 950) in the treatment of essential hypertension | |
| WO2025103426A1 (zh) | 白塞综合征的治疗 | |
| JPS61200917A (ja) | ベタキソロールとニフエジピンとを含有する医薬組成物 | |
| HK1207293B (en) | Composition for the treatment of inflammatory and immune disorders |